Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated.
OBJECTIVE
To determine whether self-selected women with polycystic ovary syndrome (PCOS) are abnormal compared with a control population.


METHODS
Case-control.


METHODS
Support group meeting organized and initiated by patients.


METHODS
Forty-five self-selected women with PCOS and 80 control women.


METHODS
Self-selected women with PCOS at a peer support conference completed a questionnaire, had a brief physical, and gave a fasting blood sample.


METHODS
Historical, biometric, and assay results.


RESULTS
Sixty percent of the women attending the conference participated in the study. Most had been diagnosed with PCOS on the basis of ovarian morphology (35%). They were more likely to be nulliparous and have a history of oligomenorrhea (96%). They were hyperandrogenemic (significantly elevated testosterone and DHEAS levels) compared with control women. Self-selected women with PCOS displayed multiple metabolic abnormalities compared with control women, including elevations in blood pressure, waist-hip ratio, fasting insulin, fasting total cholesterol, and fasting low-density lipoprotein cholesterol levels, as well as a significant decrease in fasting glucose-insulin ratio and high-density lipoprotein cholesterol levels.


CONCLUSIONS
Self-selected women with PCOS have reproductive and metabolic abnormalities. The majority of these women received inadequate treatment despite having risk factors for endometrial cancer, diabetes, and/or heart disease. Our study also suggests that women attending or participating in a PCOS support group are willing and likely to participate in clinical studies.
Legro
Richard S
RS
M.S. Hershey Medical Center, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Hershey, Pennsylvania 17033, USA. rsl1@psu.edu
Urbanek
Margrit
M
Kunselman
Allen R
AR
Leiby
Benjamin E
BE
Dunaif
Andrea
A
D000328:Adult; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D007333:Insulin Resistance; D008659:Metabolic Diseases / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D009839:Oligomenorrhea / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D010414:Pennsylvania; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000503:physiopathology* / Q000628:therapy; D015995:Prevalence; D012657:Self-Help Groups